Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-01-01 @ 1:36 PM
Study NCT ID:
NCT03797456
Status:
COMPLETED
Last Update Posted:
2024-04-18
First Post:
2019-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL)
Sponsor:
Beijing InnoCare Pharma Tech Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ICP-CL-00104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None